Boost Radiation Therapy
Showing 26 - 50 of >10,000
Breast Cancer, Adverse Effect of Radiation Therapy Trial in Chandigarh
Completed
- Breast Cancer
- Adverse Effect of Radiation Therapy
-
Chandigarh, N/A = Not Applicable, IndiaDr Budhi Singh Yadav
Jun 22, 2021
Tumor Metastasis Trial in Atlanta (Volumetric modulated arc therapy)
Completed
- Neoplasm Metastasis
- Volumetric modulated arc therapy
-
Atlanta, Georgia
- +1 more
Jun 25, 2021
Stage II Rectal Cancer Trial in Montreal (Complete responders and Non-complete responders, Chemoradiation + EBRT Boost,
Recruiting
- Stage II Rectal Cancer
- Complete responders and Non-complete responders
- +2 more
-
Montreal, Quebec, CanadaJewish General Hospital
Nov 23, 2021
Breast Cancer Trial in Montpellier (partial breast irradiation, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- partial breast irradiation
- whole breast irradiation
-
Montpellier, FranceCentre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Dec 20, 2021
Prostate Adenocarcinoma Trial in Park Ridge (CyberKnife, Androgen Deprivation Therapy (ADT), Intensity Modulated radiation
Recruiting
- Prostate Adenocarcinoma
- CyberKnife
- +2 more
-
Park Ridge, IllinoisAdvocate Lutheran General Hospital
Jul 19, 2021
Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
-
Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021
Prostate Cancer Trial in New York (PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- Prostate Cancer
- PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC
- Stereotactic Body Radiation Therapy (SBRT)
-
New York, New YorkWeill Cornell Medicine
Jul 13, 2021
Locally Advanced Anal Canal Cancer Trial in France (5Fluorouracile and Mitomycin-C, Simultaneously integrated boost of intensity
Active, not recruiting
- Locally Advanced Anal Canal Cancer
- 5Fluorouracile and Mitomycin-C
- Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
-
Angers, France
- +7 more
Dec 7, 2022
Urinary Problems, Prostate Cancer Trial in Montréal (Preventive administration of Rapaflo, Standard Care)
Recruiting
- Urinary Problems
- Prostate Cancer
- Preventive administration of Rapaflo
- Standard Care
-
Montréal, Quebec, CanadaJewish General Hospital, McGill University
Sep 20, 2021
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Prostate Cancer Trial (Radiotherapy with IMRT and CyberKnife Boost)
Active, not recruiting
- Prostate Cancer
- Radiotherapy with IMRT and CyberKnife Boost
- (no location specified)
Mar 26, 2021
Breast Cancer Trial in New York (Arm 1 Daily Boost of Radiation Therapy, Arm 2 Weekly Boost of Radiation Therapy)
Completed
- Breast Cancer
- Arm 1 Daily Boost of Radiation Therapy
- Arm 2 Weekly Boost of Radiation Therapy
-
New York, New YorkNYU Cancer Institute
Jan 15, 2021
Soft Tissue Sarcoma Trial in Florence (RT)
Recruiting
- Soft Tissue Sarcoma
- RT
-
Florence, Fi, ItalyAOU Careggi
Feb 27, 2023
Rectal Tumors Trial in Worldwide (radiation, device, drug)
Active, not recruiting
- Rectal Neoplasms
- 3D conformal EBRT
- +2 more
-
Aarhus, Denmark
- +19 more
Oct 18, 2022
Prospective Neurobehavioral Functions in Newly-diagnosed Primary
Recruiting
- Primary CNS Lymphoma
- Brain Lymphoma
- A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Mar 9, 2021
Sinonasal Malignancies:, Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses Trial in Heidelberg (carbon ion
Completed
- Sinonasal Malignancies
- Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses
- carbon ion boost
-
Heidelberg, GermanyDept of Radiation Oncology, University of Heidelberg, INF 400
Aug 29, 2022
Breast Cancer, Ductal Carcinoma in Situ Trial in Saint Louis (Mammosite ML)
Completed
- Breast Cancer
- Ductal Carcinoma in Situ
- Mammosite ML
-
Saint Louis, Missouri
- +1 more
Jun 25, 2021
Brain Metastases Trial in Innsbruck (Hippocampal Avoiding Whole Brain Radiation Therapy with Simultaneous Integrated Boost,
Recruiting
- Brain Metastases
- Hippocampal Avoiding Whole Brain Radiation Therapy with Simultaneous Integrated Boost
- Single session or hypofractionated stereotactic radiosurgery
-
Innsbruck, AustriaMedical University Innsbruck
Sep 2, 2021
Prostate Cancer, Radiotherapy Side Effect Trial in Denmark (Proton therapy, Photon therapy)
Recruiting
- Prostate Cancer
- Radiotherapy Side Effect
- Proton therapy
- Photon therapy
-
Aarhus, Central Region, Denmark
- +6 more
Apr 21, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in
Recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +5 more
- Image Guided Radiation Therapy
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2021
Breast Cancer Trial in Ann Arbor (Ribociclib, Postoperative Radiation Therapy)
Not yet recruiting
- Breast Cancer
- Ribociclib
- Postoperative Radiation Therapy
-
Ann Arbor, MichiganUniversity of Michigan
Aug 10, 2023
Small-cell Lung Cancer Trial in Beijing (SIB-IMRT, routine IMRT)
Unknown status
- Small-cell Lung Cancer
- SIB-IMRT
- routine IMRT
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Hospital, Chinese Acade
Jan 27, 2021
Pelvis Tumors Trial in Esch-sur-Alzette (Radiation treatment, CK Boost Pelvis)
Active, not recruiting
- Pelvis Tumors
- Radiation treatment
- CK Boost Pelvis
-
Esch-sur-Alzette, SUD, LuxembourgCentre Francois Baclesse
Jun 20, 2022
Treatment Trial in Shanghai (Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- Treatment
- Stereotactic Body Radiation Therapy (SBRT)
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Oct 22, 2020
Recurrent NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Columbus (radiation, drug, other)
Unknown status
- Recurrent Non-small Cell Lung Cancer
- +4 more
- hypofractionated radiation therapy
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 24, 2020